CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
REVENUES:
Net product sales	$ 2,892,942	$ 2,034,072	$ 8,320,314	$ 7,951,091
License and Royalty Revenue	227,635	33,895	327,689	56,096
R&D, milestone and grant revenue	994,237	1,198,438	1,791,977	1,860,317
TOTAL REVENUES	4,114,814	3,266,405	10,439,980	9,867,504
Cost of product sales	2,203,843	1,686,100	5,423,057	5,121,651
GROSS MARGIN	1,910,971	1,580,305	5,016,923	4,745,853
OPERATING EXPENSES:
Research and development expenses	1,982,426	2,367,466	4,228,998	4,001,764
Selling, general and administrative expenses	2,109,360	1,598,813	4,597,696	3,598,217
TOTAL OPERATING EXPENSES	4,091,786	3,966,279	8,826,694	7,599,981
LOSS FROM OPERATIONS	(2,180,815)	(2,385,974)	(3,809,771)	(2,854,128)
OTHER INCOME:
Interest income	7,722	1,310	21,104	3,874
TOTAL OTHER INCOME	7,722	1,310	21,104	3,874
LOSS BEFORE INCOME TAXES	(2,173,093)	(2,384,664)	(3,788,667)	(2,850,254)
Income tax provision	0	5,962,818	0	5,800,818
NET LOSS	$ (2,173,093)	$ (8,347,482)	$ (3,788,667)	$ (8,651,072)
Basic loss per share (in dollars per share)	$ (0.18)	$ (0.86)	$ (0.31)	$ (0.90)
Diluted loss per share (in dollars per share)	$ (0.18)	$ (0.86)	$ (0.31)	$ (0.90)
Weighted average number of shares outstanding, basic (in shares)	12,299,122	9,667,543	12,284,979	9,649,612
Weighted average number of shares outstanding, diluted (in shares)	12,299,122	9,667,543	12,284,979	9,649,612